Literature DB >> 8496586

CD22, a B cell-specific receptor, mediates adhesion and signal transduction.

E A Clark1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496586

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  23 in total

1.  Characterization of CD22 expression in acute lymphoblastic leukemia.

Authors:  Nirali N Shah; Maryalice Stetler Stevenson; Constance M Yuan; Kelly Richards; Cindy Delbrook; Robert J Kreitman; Ira Pastan; Alan S Wayne
Journal:  Pediatr Blood Cancer       Date:  2015-03-01       Impact factor: 3.167

2.  Pharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclonal antibody in Chinese patients with CD22-positive non-Hodgkin lymphoma.

Authors:  Su Li; Dongsheng Zhang; Jian Sun; Zhinming Li; Liting Deng; Benyan Zou; Jing Zhan; Wenqi Jiang
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  Differential expression of CD22 (Lyb8) on murine B cells.

Authors:  L D Erickson; L T Tygrett; S K Bhatia; K H Grabstein; T J Waldschmidt
Journal:  Int Immunol       Date:  1996-07       Impact factor: 4.823

4.  Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation.

Authors:  Yuko Naito; Hiromu Takematsu; Susumu Koyama; Shizu Miyake; Harumi Yamamoto; Reiko Fujinawa; Manabu Sugai; Yasushi Okuno; Gozoh Tsujimoto; Toshiyuki Yamaji; Yasuhiro Hashimoto; Shigeyoshi Itohara; Toshisuke Kawasaki; Akemi Suzuki; Yasunori Kozutsumi
Journal:  Mol Cell Biol       Date:  2007-02-12       Impact factor: 4.272

Review 5.  The B cell antigen receptor complex: mechanisms and implications of tyrosine kinase activation.

Authors:  J Tseng; Y J Lee; B J Eisfelder; M R Clark
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

6.  Soluble CD22 as a tumor marker for hairy cell leukemia.

Authors:  Kakushi Matsushita; Inger Margulies; Masanori Onda; Satoshi Nagata; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2008-07-02       Impact factor: 22.113

7.  Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.

Authors:  N Razi; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

8.  CD22 is required for protection against West Nile virus Infection.

Authors:  Daphne Y Ma; Mehul S Suthar; Shinji Kasahara; Michael Gale; Edward A Clark
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

9.  Epitope mapping and key amino acid identification of anti-CD22 immunotoxin CAT-8015 using hybrid β-lactamase display.

Authors:  D Bannister; B Popovic; S Sridharan; F Giannotta; P Filée; N Yilmaz; R Minter
Journal:  Protein Eng Des Sel       Date:  2010-12-14       Impact factor: 1.650

10.  CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignancies.

Authors:  Ralph F Alderson; Robert J Kreitman; Tianling Chen; Peter Yeung; Ronald Herbst; Judy A Fox; Ira Pastan
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 13.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.